Figure 3.

Unadjusted, unstratified OS for the maintenance phase (from randomization) for the Q-ITT analysis population. Pemetrexed + BSC: OS median time = 12.2 months (95% CI = 5.6-20.6). BSC: OS median time = 11.8 months (95% CI = 6.3-25.6) one-sided p-value = 0.3619.

Mubarak et al. BMC Cancer 2012 12:423   doi:10.1186/1471-2407-12-423
Download authors' original image